Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taichi Adachi

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Plos One|January 25, 2022
Topiroxostat versus allopurinol in patients with chronic heart failure complicated by hyperuricemia: A prospective, randomized, open-label, blinded-end-point clinical trialMasashi Sakuma, Shigeru Toyoda, Takuo Arikawa, et al.
Clinical and Experimental Nephrology|June 20, 2018
The effects of xanthine oxidase inhibitor in patients with chronic heart failure complicated with hyperuricemia: a prospective randomized controlled clinical trial of topiroxostat vs allopurinol-study protocolMasashi Sakuma, Shigeru Toyoda, Takuo Arikawa, et al.
Cardiovascular Drugs and Therapy|November 4, 2017
Rationale and Design of Low-dose Administration of Carperitide for Acute Heart Failure (LASCAR-AHF)Toshiyuki Nagai, Yasuyuki Honda, Hiroki Nakano, et al.
Drug Discoveries & Therapeutics|October 15, 2025
Tapeworm infection incidence in rural Japan points to a common environmental source of infectionDhammika Leshan Wannigama, Mohan Amarasiri, Phatthranit Phattharapornjaroen, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Plos One|January 25, 2022
Topiroxostat versus allopurinol in patients with chronic heart failure complicated by hyperuricemia: A prospective, randomized, open-label, blinded-end-point clinical trialMasashi Sakuma, Shigeru Toyoda, Takuo Arikawa, et al.
Clinical and Experimental Nephrology|June 20, 2018
The effects of xanthine oxidase inhibitor in patients with chronic heart failure complicated with hyperuricemia: a prospective randomized controlled clinical trial of topiroxostat vs allopurinol-study protocolMasashi Sakuma, Shigeru Toyoda, Takuo Arikawa, et al.
Cardiovascular Drugs and Therapy|November 4, 2017
Rationale and Design of Low-dose Administration of Carperitide for Acute Heart Failure (LASCAR-AHF)Toshiyuki Nagai, Yasuyuki Honda, Hiroki Nakano, et al.
Drug Discoveries & Therapeutics|October 15, 2025
Tapeworm infection incidence in rural Japan points to a common environmental source of infectionDhammika Leshan Wannigama, Mohan Amarasiri, Phatthranit Phattharapornjaroen, et al.
Pageof 2